Knowing Now
Moves Us
Knowledge empowers us to navigate through life’s choices and decisions. With solutions that provide real-time, definitive results; at Sapphiros we work together to help global communities act on these insights with confidence.
Our Technologies
Putting next‑generation diagnostics in your hands
Showcasing the platforms enabling near‑patient and at‑home testing—designed for speed, accuracy, and scale.
Molecular
Our molecular detection technologies enable near‑patient and over‑the‑counter testing for infectious disease or genetic indications.
Digital Lateral Flow
Establishes a new category with digital lateral flow at the cost of goods of a visual lateral flow.
Visual Lateral Flow
Innovative product format delivering the lowest‑cost visual lateral flow with extreme‑volume manufacturing capacity.
Family of Companies
Sapphiros Cambridge aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near patient and at-home testing for infectious disease or generic indications.
Sapphiros Hove is a material and process innovation and technology centre of excellence, with high speed printed electronics manufacturing, in-house proprietary conductive inks and printed components.
The SatioPatch™ Platform provides consumer-based diagnosis through a convenient and simple to use patch for rapid, point of care diagnosis.
Sapphiros Laboratories is a leading provider of genetic and COVID-19 testing.
GrapheneDx is designing a device that will put the power of the highest performing diagnostics in the palm of your hand and in the comfort of your home.
Previous slide
Next slide
Our Values
We Innovate Together
We work as a team to deliver extraordinary and disruptive
innovation & technology that changes healthcare
We Care for Each Other
We care: for each other, our customers and our partners
We Deliver on our commitments
Individually and as a team we are accountable to deliver on our commitments and always focus on creating value for our customers, investors and partners